Xinxiang Xunmatang Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xinxiang Xunmatang Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include WARMBIODER. The owner is based in Xinxiang City, Henan Province.

Room 1601,Unit 1,Bldg 3,Golden Harbor,

Puxi Subdistrict Office,Changyuan City,

Xinxiang City, Henan Province 453400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xinxiang Xunmatang Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Xinxiang Xunmatang Biotechnology Co., Ltd. have?

Xinxiang Xunmatang Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xinxiang Xunmatang Biotechnology Co., Ltd. file in?

Xinxiang Xunmatang Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Xinxiang Xunmatang Biotechnology Co., Ltd.'s most well-known trademarks?

Xinxiang Xunmatang Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as WARMBIODER. These are among 1 currently registered trademark in the portfolio.

What is Xinxiang Xunmatang Biotechnology Co., Ltd.'s trademark registration success rate?

Xinxiang Xunmatang Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.